Appropriate PD-L1 Cutoff Value for Gastric Cancer Immunotherapy: A Systematic Review and Meta-Analysis

BACKGROUND: Immunotherapy dramatically changed the treatment landscape of gastric cancer in recent years. PD-L1 expression was proposed as a biomarker; however, the treatment strategy according to PD-L1 is still uncertain. Here, we aimed to find the appropriate cutoff value of PD-L1 expression for g...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Tong, Zhang, Zhening, Zhang, Xiaotian, Qi, Changsong, Shen, Lin, Peng, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440909/
https://www.ncbi.nlm.nih.gov/pubmed/34540656
http://dx.doi.org/10.3389/fonc.2021.646355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440909/
https://www.ncbi.nlm.nih.gov/pubmed/34540656
http://dx.doi.org/10.3389/fonc.2021.646355

Ejemplares similares